Globe Newswire
Global Nuclear Medicine Radioisotope Market to Reach US$36. 9 Billion by the Year 2027. Amid the COVID-19 crisis, the global market for Nuclear Medicine Radioisotope estimated at US$17. 1 Billion in the year 2020, is projected to reach a revised size of US$36.New York, Jan. 19, 2021 (GLOBE NEWSWIRE) -- Reportlinker.com announces the release of the report "Global Nuclear Medicine Radioisotope Industry" - https://www.reportlinker.com/p05957532/?utm_source=GNW 9 Billion by 2027, growing at a CAGR of 11.6% over the analysis period 2020-2027.Technetium-99m (Tc-99m), one of the segments analyzed in the report, is projected to grow at a 12.3% CAGR to reach US$24.8 Billion by the end of the analysis period.After an early analysis of the business implications of the pandemic and its induced economic crisis, growth in the Thallium-201 (Tl-201) segment is readjusted to a revised 10.6% CAGR for the next 7-year period. This segment currently accounts for a 10.4% share of the global Nuclear Medicine Radioisotope market. The U.S. Accounts for Over 29.5% of Global Market Size in 2020, While China is Forecast to Grow at a 11.1% CAGR for the Period of 2020-2027 The Nuclear Medicine Radioisotope market in the U.S. is estimated at US$5.1 Billion in the year 2020. The country currently accounts for a 29.51% share in the global market. China, the world second largest economy, is forecast to reach an estimated market size of US$6.4 Billion in the year 2027 trailing a CAGR of 11.1% through 2027. Among the other noteworthy geographic markets are Japan and Canada, each forecast to grow at 10.3% and 9.7% respectively over the 2020-2027 period. Within Europe, Germany is forecast to grow at approximately 8.3% CAGR while Rest of European market (as defined in the study) will reach US$6.4 Billion by the year 2027. Iodine (I-123) Segment Corners a 8.6% Share in 2020 In the global Iodine (I-123) segment, USA, Canada, Japan, China and Europe will drive the 11.1% CAGR estimated for this segment. These regional markets accounting for a combined market size of US$1.2 Billion in the year 2020 will reach a projected size of US$2.5 Billion by the close of the analysis period. China will remain among the fastest growing in this cluster of regional markets. Led by countries such as Australia, India, and South Korea, the market in Asia-Pacific is forecast to reach US$4.3 Billion by the year 2027.We bring years of research experience to this 9th edition of our report. The 192-page report presents concise insights into how the pandemic has impacted production and the buy side for 2020 and 2021. A short-term phased recovery by key geography is also addressed. Competitors identified in this market include, among others, Bayer Healthcare AGBracco Imaging SpACardinal Health, Inc.GE HealthcareHologic, Inc.Lantheus Medical Imaging, Inc.Medtronic PLCNTP Radioisotopes SOC Ltd.Positron CorporationSiemens Healthineers Read the full report: https://www.reportlinker.com/p05957532/?utm_source=GNW I. INTRODUCTION, METHODOLOGY & REPORT SCOPE II. EXECUTIVE SUMMARY 1. MARKET OVERVIEW Impact of Covid-19 and a Looming Global Recession Global Competitor Market Shares Nuclear Medicine Radioisotope Competitor Market Share Scenario Worldwide (in %): 2018E 2. FOCUS ON SELECT PLAYERS 3. MARKET TRENDS & DRIVERS 4. GLOBAL MARKET PERSPECTIVE Table 1: World Current & Future Analysis for Nuclear Medicine Radioisotope by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Billion for Years 2018 through 2027 Table 2: World Historic Review for Nuclear Medicine Radioisotope by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Billion for Years 2012 through 2017 Table 3: World 15-Year Perspective for Nuclear Medicine Radioisotope by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets for Years 2012, 2018 & 2027 Table 4: World Current & Future Analysis for Technetium-99m (Tc-99m) by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Billion for Years 2018 through 2027 Table 5: World Historic Review for Technetium-99m (Tc-99m) by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Billion for Years 2012 through 2017 Table 6: World 15-Year Perspective for Technetium-99m (Tc-99m) by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World for Years 2012, 2018 & 2027 Table 7: World Current & Future Analysis for Thallium-201 (Tl-201) by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Billion for Years 2018 through 2027 Table 8: World Historic Review for Thallium-201 (Tl-201) by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Billion for Years 2012 through 2017 Table 9: World 15-Year Perspective for Thallium-201 (Tl-201) by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World for Years 2012, 2018 & 2027 Table 10: World Current & Future Analysis for Iodine (I-123) by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Billion for Years 2018 through 2027 Table 11: World Historic Review for Iodine (I-123) by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Billion for Years 2012 through 2017 Table 12: World 15-Year Perspective for Iodine (I-123) by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World for Years 2012, 2018 & 2027 Table 13: World Current & Future Analysis for Gallium-67 (Ga-67) by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Billion for Years 2018 through 2027 Table 14: World Historic Review for Gallium-67 (Ga-67) by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Billion for Years 2012 through 2017 Table 15: World 15-Year Perspective for Gallium-67 (Ga-67) by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World for Years 2012, 2018 & 2027 Table 16: World Current & Future Analysis for Other Type of Radioisotopes by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Billion for Years 2018 through 2027 Table 17: World Historic Review for Other Type of Radioisotopes by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Billion for Years 2012 through 2017 Table 18: World 15-Year Perspective for Other Type of Radioisotopes by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World for Years 2012, 2018 & 2027 Table 19: World Current & Future Analysis for Oncology by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Billion for Years 2018 through 2027 Table 20: World Historic Review for Oncology by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Billion for Years 2012 through 2017 Table 21: World 15-Year Perspective for Oncology by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World for Years 2012, 2018 & 2027 Table 22: World Current & Future Analysis for Cardiology by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Billion for Years 2018 through 2027 Table 23: World Historic Review for Cardiology by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Billion for Years 2012 through 2017 Table 24: World 15-Year Perspective for Cardiology by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World for Years 2012, 2018 & 2027 Table 25: World Current & Future Analysis for Lymphoma by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Billion for Years 2018 through 2027 Table 26: World Historic Review for Lymphoma by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Billion for Years 2012 through 2017 Table 27: World 15-Year Perspective for Lymphoma by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World for Years 2012, 2018 & 2027 Table 28: World Current & Future Analysis for Thyroid by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Billion for Years 2018 through 2027 Table 29: World Historic Review for Thyroid by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Billion for Years 2012 through 2017 Table 30: World 15-Year Perspective for Thyroid by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World for Years 2012, 2018 & 2027 Table 31: World Current & Future Analysis for Neurology by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Billion for Years 2018 through 2027 Table 32: World Historic Review for Neurology by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Billion for Years 2012 through 2017 Table 33: World 15-Year Perspective for Neurology by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World for Years 2012, 2018 & 2027 Table 34: World Current & Future Analysis for Other Applications by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Billion for Years 2018 through 2027 Table 35: World Historic Review for Other Applications by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Billion for Years 2012 through 2017 Table 36: World 15-Year Perspective for Other Applications by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World for Years 2012, 2018 & 2027 III. MARKET ANALYSIS GEOGRAPHIC MARKET ANALYSIS UNITED STATES Market Facts & Figures US Nuclear Medicine Radioisotope Market Share (in %) by Company: 2018 & 2027 Market Analytics Table 37: USA Current & Future Analysis for Nuclear Medicine Radioisotope by Type of Radioisotope - Technetium-99m (Tc-99m), Thallium-201 (Tl-201), Iodine (I-123), Gallium-67 (Ga-67) and Other Type of Radioisotopes - Independent Analysis of Annual Sales in US$ Billion for the Years 2018 through 2027 Table 38: USA Historic Review for Nuclear Medicine Radioisotope by Type of Radioisotope - Technetium-99m (Tc-99m), Thallium-201 (Tl-201), Iodine (I-123), Gallium-67 (Ga-67) and Other Type of Radioisotopes Markets - Independent Analysis of Annual Sales in US$ Billion for Years 2012 through 2017 Table 39: USA 15-Year Perspective for Nuclear Medicine Radioisotope by Type of Radioisotope - Percentage Breakdown of Value Sales for Technetium-99m (Tc-99m), Thallium-201 (Tl-201), Iodine (I-123), Gallium-67 (Ga-67) and Other Type of Radioisotopes for the Years 2012, 2018 & 2027 Table 40: USA Current & Future Analysis for Nuclear Medicine Radioisotope by Application - Oncology, Cardiology, Lymphoma, Thyroid, Neurology and Other Applications - Independent Analysis of Annual Sales in US$ Billion for the Years 2018 through 2027 Table 41: USA Historic Review for Nuclear Medicine Radioisotope by Application - Oncology, Cardiology, Lymphoma, Thyroid, Neurology and Other Applications Markets - Independent Analysis of Annual Sales in US$ Billion for Years 2012 through 2017 Table 42: USA 15-Year Perspective for Nuclear Medicine Radioisotope by Application - Percentage Breakdown of Value Sales for Oncology, Cardiology, Lymphoma, Thyroid, Neurology and Other Applications for the Years 2012, 2018 & 2027 CANADA Table 43: Canada Current & Future Analysis for Nuclear Medicine Radioisotope by Type of Radioisotope - Technetium-99m (Tc-99m), Thallium-201 (Tl-201), Iodine (I-123), Gallium-67 (Ga-67) and Other Type of Radioisotopes - Independent Analysis of Annual Sales in US$ Billion for the Years 2018 through 2027 Table 44: Canada Historic Review for Nuclear Medicine Radioisotope by Type of Radioisotope - Technetium-99m (Tc-99m), Thallium-201 (Tl-201), Iodine (I-123), Gallium-67 (Ga-67) and Other Type of Radioisotopes Markets - Independent Analysis of Annual Sales in US$ Billion for Years 2012 through 2017 Table 45: Canada 15-Year Perspective for Nuclear Medicine Radioisotope by Type of Radioisotope - Percentage Breakdown of Value Sales for Technetium-99m (Tc-99m), Thallium-201 (Tl-201), Iodine (I-123), Gallium-67 (Ga-67) and Other Type of Radioisotopes for the Years 2012, 2018 & 2027 Table 46: Canada Current & Future Analysis for Nuclear Medicine Radioisotope by Application - Oncology, Cardiology, Lymphoma, Thyroid, Neurology and Other Applications - Independent Analysis of Annual Sales in US$ Billion for the Years 2018 through 2027 Table 47: Canada Historic Review for Nuclear Medicine Radioisotope by Application - Oncology, Cardiology, Lymphoma, Thyroid, Neurology and Other Applications Markets - Independent Analysis of Annual Sales in US$ Billion for Years 2012 through 2017 Table 48: Canada 15-Year Perspective for Nuclear Medicine Radioisotope by Application - Percentage Breakdown of Value Sales for Oncology, Cardiology, Lymphoma, Thyroid, Neurology and Other Applications for the Years 2012, 2018 & 2027 JAPAN Table 49: Japan Current & Future Analysis for Nuclear Medicine Radioisotope by Type of Radioisotope - Technetium-99m (Tc-99m), Thallium-201 (Tl-201), Iodine (I-123), Gallium-67 (Ga-67) and Other Type of Radioisotopes - Independent Analysis of Annual Sales in US$ Billion for the Years 2018 through 2027 Table 50: Japan Historic Review for Nuclear Medicine Radioisotope by Type of Radioisotope - Technetium-99m (Tc-99m), Thallium-201 (Tl-201), Iodine (I-123), Gallium-67 (Ga-67) and Other Type of Radioisotopes Markets - Independent Analysis of Annual Sales in US$ Billion for Years 2012 through 2017 Table 51: Japan 15-Year Perspective for Nuclear Medicine Radioisotope by Type of Radioisotope - Percentage Breakdown of Value Sales for Technetium-99m (Tc-99m), Thallium-201 (Tl-201), Iodine (I-123), Gallium-67 (Ga-67) and Other Type of Radioisotopes for the Years 2012, 2018 & 2027 Table 52: Japan Current & Future Analysis for Nuclear Medicine Radioisotope by Application - Oncology, Cardiology, Lymphoma, Thyroid, Neurology and Other Applications - Independent Analysis of Annual Sales in US$ Billion for the Years 2018 through 2027 Table 53: Japan Historic Review for Nuclear Medicine Radioisotope by Application - Oncology, Cardiology, Lymphoma, Thyroid, Neurology and Other Applications Markets - Independent Analysis of Annual Sales in US$ Billion for Years 2012 through 2017 Table 54: Japan 15-Year Perspective for Nuclear Medicine Radioisotope by Application - Percentage Breakdown of Value Sales for Oncology, Cardiology, Lymphoma, Thyroid, Neurology and Other Applications for the Years 2012, 2018 & 2027 CHINA Table 55: China Current & Future Analysis for Nuclear Medicine Radioisotope by Type of Radioisotope - Technetium-99m (Tc-99m), Thallium-201 (Tl-201), Iodine (I-123), Gallium-67 (Ga-67) and Other Type of Radioisotopes - Independent Analysis of Annual Sales in US$ Billion for the Years 2018 through 2027 Table 56: China Historic Review for Nuclear Medicine Radioisotope by Type of Radioisotope - Technetium-99m (Tc-99m), Thallium-201 (Tl-201), Iodine (I-123), Gallium-67 (Ga-67) and Other Type of Radioisotopes Markets - Independent Analysis of Annual Sales in US$ Billion for Years 2012 through 2017 Table 57: China 15-Year Perspective for Nuclear Medicine Radioisotope by Type of Radioisotope - Percentage Breakdown of Value Sales for Technetium-99m (Tc-99m), Thallium-201 (Tl-201), Iodine (I-123), Gallium-67 (Ga-67) and Other Type of Radioisotopes for the Years 2012, 2018 & 2027 Table 58: China Current & Future Analysis for Nuclear Medicine Radioisotope by Application - Oncology, Cardiology, Lymphoma, Thyroid, Neurology and Other Applications - Independent Analysis of Annual Sales in US$ Billion for the Years 2018 through 2027 Table 59: China Historic Review for Nuclear Medicine Radioisotope by Application - Oncology, Cardiology, Lymphoma, Thyroid, Neurology and Other Applications Markets - Independent Analysis of Annual Sales in US$ Billion for Years 2012 through 2017 Table 60: China 15-Year Perspective for Nuclear Medicine Radioisotope by Application - Percentage Breakdown of Value Sales for Oncology, Cardiology, Lymphoma, Thyroid, Neurology and Other Applications for the Years 2012, 2018 & 2027 EUROPE Market Facts & Figures European Nuclear Medicine Radioisotope Market: Competitor Market Share Scenario (in %) for 2018 & 2027 Market Analytics Table 61: Europe Current & Future Analysis for Nuclear Medicine Radioisotope by Geographic Region - France, Germany, Italy, UK and Rest of Europe Markets - Independent Analysis of Annual Sales in US$ Billion for Years 2018 through 2027 Table 62: Europe Historic Review for Nuclear Medicine Radioisotope by Geographic Region - France, Germany, Italy, UK and Rest of Europe Markets - Independent Analysis of Annual Sales in US$ Billion for Years 2012 through 2017 Table 63: Europe 15-Year Perspective for Nuclear Medicine Radioisotope by Geographic Region - Percentage Breakdown of Value Sales for France, Germany, Italy, UK and Rest of Europe Markets for Years 2012, 2018 & 2027 Table 64: Europe Current & Future Analysis for Nuclear Medicine Radioisotope by Type of Radioisotope - Technetium-99m (Tc-99m), Thallium-201 (Tl-201), Iodine (I-123), Gallium-67 (Ga-67) and Other Type of Radioisotopes - Independent Analysis of Annual Sales in US$ Billion for the Years 2018 through 2027 Table 65: Europe Historic Review for Nuclear Medicine Radioisotope by Type of Radioisotope - Technetium-99m (Tc-99m), Thallium-201 (Tl-201), Iodine (I-123), Gallium-67 (Ga-67) and Other Type of Radioisotopes Markets - Independent Analysis of Annual Sales in US$ Billion for Years 2012 through 2017 Table 66: Europe 15-Year Perspective for Nuclear Medicine Radioisotope by Type of Radioisotope - Percentage Breakdown of Value Sales for Technetium-99m (Tc-99m), Thallium-201 (Tl-201), Iodine (I-123), Gallium-67 (Ga-67) and Other Type of Radioisotopes for the Years 2012, 2018 & 2027 Table 67: Europe Current & Future Analysis for Nuclear Medicine Radioisotope by Application - Oncology, Cardiology, Lymphoma, Thyroid, Neurology and Other Applications - Independent Analysis of Annual Sales in US$ Billion for the Years 2018 through 2027 Table 68: Europe Historic Review for Nuclear Medicine Radioisotope by Application - Oncology, Cardiology, Lymphoma, Thyroid, Neurology and Other Applications Markets - Independent Analysis of Annual Sales in US$ Billion for Years 2012 through 2017 Table 69: Europe 15-Year Perspective for Nuclear Medicine Radioisotope by Application - Percentage Breakdown of Value Sales for Oncology, Cardiology, Lymphoma, Thyroid, Neurology and Other Applications for the Years 2012, 2018 & 2027 FRANCE Table 70: France Current & Future Analysis for Nuclear Medicine Radioisotope by Type of Radioisotope - Technetium-99m (Tc-99m), Thallium-201 (Tl-201), Iodine (I-123), Gallium-67 (Ga-67) and Other Type of Radioisotopes - Independent Analysis of Annual Sales in US$ Billion for the Years 2018 through 2027 Table 71: France Historic Review for Nuclear Medicine Radioisotope by Type of Radioisotope - Technetium-99m (Tc-99m), Thallium-201 (Tl-201), Iodine (I-123), Gallium-67 (Ga-67) and Other Type of Radioisotopes Markets - Independent Analysis of Annual Sales in US$ Billion for Years 2012 through 2017 Table 72: France 15-Year Perspective for Nuclear Medicine Radioisotope by Type of Radioisotope - Percentage Breakdown of Value Sales for Technetium-99m (Tc-99m), Thallium-201 (Tl-201), Iodine (I-123), Gallium-67 (Ga-67) and Other Type of Radioisotopes for the Years 2012, 2018 & 2027 Table 73: France Current & Future Analysis for Nuclear Medicine Radioisotope by Application - Oncology, Cardiology, Lymphoma, Thyroid, Neurology and Other Applications - Independent Analysis of Annual Sales in US$ Billion for the Years 2018 through 2027 Table 74: France Historic Review for Nuclear Medicine Radioisotope by Application - Oncology, Cardiology, Lymphoma, Thyroid, Neurology and Other Applications Markets - Independent Analysis of Annual Sales in US$ Billion for Years 2012 through 2017 Table 75: France 15-Year Perspective for Nuclear Medicine Radioisotope by Application - Percentage Breakdown of Value Sales for Oncology, Cardiology, Lymphoma, Thyroid, Neurology and Other Applications for the Years 2012, 2018 & 2027 GERMANY Table 76: Germany Current & Future Analysis for Nuclear Medicine Radioisotope by Type of Radioisotope - Technetium-99m (Tc-99m), Thallium-201 (Tl-201), Iodine (I-123), Gallium-67 (Ga-67) and Other Type of Radioisotopes - Independent Analysis of Annual Sales in US$ Billion for the Years 2018 through 2027 Table 77: Germany Historic Review for Nuclear Medicine Radioisotope by Type of Radioisotope - Technetium-99m (Tc-99m), Thallium-201 (Tl-201), Iodine (I-123), Gallium-67 (Ga-67) and Other Type of Radioisotopes Markets - Independent Analysis of Annual Sales in US$ Billion for Years 2012 through 2017 Table 78: Germany 15-Year Perspective for Nuclear Medicine Radioisotope by Type of Radioisotope - Percentage Breakdown of Value Sales for Technetium-99m (Tc-99m), Thallium-201 (Tl-201), Iodine (I-123), Gallium-67 (Ga-67) and Other Type of Radioisotopes for the Years 2012, 2018 & 2027 Table 79: Germany Current & Future Analysis for Nuclear Medicine Radioisotope by Application - Oncology, Cardiology, Lymphoma, Thyroid, Neurology and Other Applications - Independent Analysis of Annual Sales in US$ Billion for the Years 2018 through 2027 Table 80: Germany Historic Review for Nuclear Medicine Radioisotope by Application - Oncology, Cardiology, Lymphoma, Thyroid, Neurology and Other Applications Markets - Independent Analysis of Annual Sales in US$ Billion for Years 2012 through 2017 Table 81: Germany 15-Year Perspective for Nuclear Medicine Radioisotope by Application - Percentage Breakdown of Value Sales for Oncology, Cardiology, Lymphoma, Thyroid, Neurology and Other Applications for the Years 2012, 2018 & 2027 ITALY Table 82: Italy Current & Future Analysis for Nuclear Medicine Radioisotope by Type of Radioisotope - Technetium-99m (Tc-99m), Thallium-201 (Tl-201), Iodine (I-123), Gallium-67 (Ga-67) and Other Type of Radioisotopes - Independent Analysis of Annual Sales in US$ Billion for the Years 2018 through 2027 Table 83: Italy Historic Review for Nuclear Medicine Radioisotope by Type of Radioisotope - Technetium-99m (Tc-99m), Thallium-201 (Tl-201), Iodine (I-123), Gallium-67 (Ga-67) and Other Type of Radioisotopes Markets - Independent Analysis of Annual Sales in US$ Billion for Years 2012 through 2017 Table 84: Italy 15-Year Perspective for Nuclear Medicine Radioisotope by Type of Radioisotope - Percentage Breakdown of Value Sales for Technetium-99m (Tc-99m), Thallium-201 (Tl-201), Iodine (I-123), Gallium-67 (Ga-67) and Other Type of Radioisotopes for the Years 2012, 2018 & 2027 Table 85: Italy Current & Future Analysis for Nuclear Medicine Radioisotope by Application - Oncology, Cardiology, Lymphoma, Thyroid, Neurology and Other Applications - Independent Analysis of Annual Sales in US$ Billion for the Years 2018 through 2027 Table 86: Italy Historic Review for Nuclear Medicine Radioisotope by Application - Oncology, Cardiology, Lymphoma, Thyroid, Neurology and Other Applications Markets - Independent Analysis of Annual Sales in US$ Billion for Years 2012 through 2017 Table 87: Italy 15-Year Perspective for Nuclear Medicine Radioisotope by Application - Percentage Breakdown of Value Sales for Oncology, Cardiology, Lymphoma, Thyroid, Neurology and Other Applications for the Years 2012, 2018 & 2027 UNITED KINGDOM Table 88: UK Current & Future Analysis for Nuclear Medicine Radioisotope by Type of Radioisotope - Technetium-99m (Tc-99m), Thallium-201 (Tl-201), Iodine (I-123), Gallium-67 (Ga-67) and Other Type of Radioisotopes - Independent Analysis of Annual Sales in US$ Billion for the Years 2018 through 2027 Table 89: UK Historic Review for Nuclear Medicine Radioisotope by Type of Radioisotope - Technetium-99m (Tc-99m), Thallium-201 (Tl-201), Iodine (I-123), Gallium-67 (Ga-67) and Other Type of Radioisotopes Markets - Independent Analysis of Annual Sales in US$ Billion for Years 2012 through 2017 Table 90: UK 15-Year Perspective for Nuclear Medicine Radioisotope by Type of Radioisotope - Percentage Breakdown of Value Sales for Technetium-99m (Tc-99m), Thallium-201 (Tl-201), Iodine (I-123), Gallium-67 (Ga-67) and Other Type of Radioisotopes for the Years 2012, 2018 & 2027 Table 91: UK Current & Future Analysis for Nuclear Medicine Radioisotope by Application - Oncology, Cardiology, Lymphoma, Thyroid, Neurology and Other Applications - Independent Analysis of Annual Sales in US$ Billion for the Years 2018 through 2027 Table 92: UK Historic Review for Nuclear Medicine Radioisotope by Application - Oncology, Cardiology, Lymphoma, Thyroid, Neurology and Other Applications Markets - Independent Analysis of Annual Sales in US$ Billion for Years 2012 through 2017 Table 93: UK 15-Year Perspective for Nuclear Medicine Radioisotope by Application - Percentage Breakdown of Value Sales for Oncology, Cardiology, Lymphoma, Thyroid, Neurology and Other Applications for the Years 2012, 2018 & 2027 REST OF EUROPE Table 94: Rest of Europe Current & Future Analysis for Nuclear Medicine Radioisotope by Type of Radioisotope - Technetium-99m (Tc-99m), Thallium-201 (Tl-201), Iodine (I-123), Gallium-67 (Ga-67) and Other Type of Radioisotopes - Independent Analysis of Annual Sales in US$ Billion for the Years 2018 through 2027 Table 95: Rest of Europe Historic Review for Nuclear Medicine Radioisotope by Type of Radioisotope - Technetium-99m (Tc-99m), Thallium-201 (Tl-201), Iodine (I-123), Gallium-67 (Ga-67) and Other Type of Radioisotopes Markets - Independent Analysis of Annual Sales in US$ Billion for Years 2012 through 2017 Table 96: Rest of Europe 15-Year Perspective for Nuclear Medicine Radioisotope by Type of Radioisotope - Percentage Breakdown of Value Sales for Technetium-99m (Tc-99m), Thallium-201 (Tl-201), Iodine (I-123), Gallium-67 (Ga-67) and Other Type of Radioisotopes for the Years 2012, 2018 & 2027 Table 97: Rest of Europe Current & Future Analysis for Nuclear Medicine Radioisotope by Application - Oncology, Cardiology, Lymphoma, Thyroid, Neurology and Other Applications - Independent Analysis of Annual Sales in US$ Billion for the Years 2018 through 2027 Table 98: Rest of Europe Historic Review for Nuclear Medicine Radioisotope by Application - Oncology, Cardiology, Lymphoma, Thyroid, Neurology and Other Applications Markets - Independent Analysis of Annual Sales in US$ Billion for Years 2012 through 2017 Table 99: Rest of Europe 15-Year Perspective for Nuclear Medicine Radioisotope by Application - Percentage Breakdown of Value Sales for Oncology, Cardiology, Lymphoma, Thyroid, Neurology and Other Applications for the Years 2012, 2018 & 2027 ASIA-PACIFIC Table 100: Asia-Pacific Current & Future Analysis for Nuclear Medicine Radioisotope by Type of Radioisotope - Technetium-99m (Tc-99m), Thallium-201 (Tl-201), Iodine (I-123), Gallium-67 (Ga-67) and Other Type of Radioisotopes - Independent Analysis of Annual Sales in US$ Billion for the Years 2018 through 2027 Table 101: Asia-Pacific Historic Review for Nuclear Medicine Radioisotope by Type of Radioisotope - Technetium-99m (Tc-99m), Thallium-201 (Tl-201), Iodine (I-123), Gallium-67 (Ga-67) and Other Type of Radioisotopes Markets - Independent Analysis of Annual Sales in US$ Billion for Years 2012 through 2017 Table 102: Asia-Pacific 15-Year Perspective for Nuclear Medicine Radioisotope by Type of Radioisotope - Percentage Breakdown of Value Sales for Technetium-99m (Tc-99m), Thallium-201 (Tl-201), Iodine (I-123), Gallium-67 (Ga-67) and Other Type of Radioisotopes for the Years 2012, 2018 & 2027 Table 103: Asia-Pacific Current & Future Analysis for Nuclear Medicine Radioisotope by Application - Oncology, Cardiology, Lymphoma, Thyroid, Neurology and Other Applications - Independent Analysis of Annual Sales in US$ Billion for the Years 2018 through 2027 Table 104: Asia-Pacific Historic Review for Nuclear Medicine Radioisotope by Application - Oncology, Cardiology, Lymphoma, Thyroid, Neurology and Other Applications Markets - Independent Analysis of Annual Sales in US$ Billion for Years 2012 through 2017 Table 105: Asia-Pacific 15-Year Perspective for Nuclear Medicine Radioisotope by Application - Percentage Breakdown of Value Sales for Oncology, Cardiology, Lymphoma, Thyroid, Neurology and Other Applications for the Years 2012, 2018 & 2027 REST OF WORLD Table 106: Rest of World Current & Future Analysis for Nuclear Medicine Radioisotope by Type of Radioisotope - Technetium-99m (Tc-99m), Thallium-201 (Tl-201), Iodine (I-123), Gallium-67 (Ga-67) and Other Type of Radioisotopes - Independent Analysis of Annual Sales in US$ Billion for the Years 2018 through 2027 Table 107: Rest of World Historic Review for Nuclear Medicine Radioisotope by Type of Radioisotope - Technetium-99m (Tc-99m), Thallium-201 (Tl-201), Iodine (I-123), Gallium-67 (Ga-67) and Other Type of Radioisotopes Markets - Independent Analysis of Annual Sales in US$ Billion for Years 2012 through 2017 Table 108: Rest of World 15-Year Perspective for Nuclear Medicine Radioisotope by Type of Radioisotope - Percentage Breakdown of Value Sales for Technetium-99m (Tc-99m), Thallium-201 (Tl-201), Iodine (I-123), Gallium-67 (Ga-67) and Other Type of Radioisotopes for the Years 2012, 2018 & 2027 Table 109: Rest of World Current & Future Analysis for Nuclear Medicine Radioisotope by Application - Oncology, Cardiology, Lymphoma, Thyroid, Neurology and Other Applications - Independent Analysis of Annual Sales in US$ Billion for the Years 2018 through 2027 Table 110: Rest of World Historic Review for Nuclear Medicine Radioisotope by Application - Oncology, Cardiology, Lymphoma, Thyroid, Neurology and Other Applications Markets - Independent Analysis of Annual Sales in US$ Billion for Years 2012 through 2017 Table 111: Rest of World 15-Year Perspective for Nuclear Medicine Radioisotope by Application - Percentage Breakdown of Value Sales for Oncology, Cardiology, Lymphoma, Thyroid, Neurology and Other Applications for the Years 2012, 2018 & 2027 IV. COMPETITION Total Companies Profiled: 55Read the full report: https://www.reportlinker.com/p05957532/?utm_source=GNWAbout ReportlinkerReportLinker is an award-winning market research solution. Reportlinker finds and organizes the latest industry data so you get all the market research you need - instantly, in one place.__________________________ CONTACT: Clare: clare@reportlinker.com US: (339)-368-6001 Intl: +1 339-368-6001